Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report: Hepatitis E during vedolizumab therapy in IBD

by de Man, R.A, de Vries, A.C, Goetgebuer, R.L, Masclee, G.M.C, van der Eijk, A.A, van der Woude, C.J
Published 2022

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study

by Feuerstein, J.D, Poylin, V.Y, Serrato, J.C, Valle, J.P.D
Published 2022